Jia Fan

Researcher Next ID · RN-005284

Researcher · Medicine

Nanjing, China

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Hepatocellular Carcinoma Treatment and Prognosis

Cholangiocarcinoma and Gallbladder Cancer Studies

Cancer Immunotherapy and Biomarkers

Ferroptosis and cancer prognosis

RNA modifications and cancer

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00252-7
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Cell · 2019 · https://doi.org/10.1016/j.cell.2019.08.052
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Nature · 2019 · https://doi.org/10.1038/s41586-019-0987-8
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
Clinical Cancer Research · 2014 · https://doi.org/10.1158/1078-0432.ccr-14-0442
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.4565

No projects listed.